Arcutis Other Operating Expenses from 2010 to 2025

ARQT Stock  USD 13.60  0.11  0.80%   
Arcutis Biotherapeutics Other Operating Expenses yearly trend continues to be comparatively stable with very little volatility. Other Operating Expenses is likely to outpace its year average in 2025. Other Operating Expenses is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. View All Fundamentals
 
Other Operating Expenses  
First Reported
2018-12-31
Previous Quarter
80.9 M
Current Value
83.8 M
Quarterly Volatility
29.1 M
 
Covid
Check Arcutis Biotherapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arcutis Biotherapeutics' main balance sheet or income statement drivers, such as Interest Expense of 35.9 M, Selling General Administrative of 209.5 M or Total Revenue of 72 M, as well as many indicators such as Price To Sales Ratio of 4.1, Dividend Yield of 0.0 or PTB Ratio of 2.39. Arcutis financial statements analysis is a perfect complement when working with Arcutis Biotherapeutics Valuation or Volatility modules.
  
Check out the analysis of Arcutis Biotherapeutics Correlation against competitors.
For more information on how to buy Arcutis Stock please use our How to Invest in Arcutis Biotherapeutics guide.

Latest Arcutis Biotherapeutics' Other Operating Expenses Growth Pattern

Below is the plot of the Other Operating Expenses of Arcutis Biotherapeutics over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Arcutis Biotherapeutics. It is also known as Arcutis Biotherapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. Arcutis Biotherapeutics' Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arcutis Biotherapeutics' overall financial position and show how it may be relating to other accounts over time.
Other Operating Expenses10 Years Trend
Slightly volatile
   Other Operating Expenses   
       Timeline  

Arcutis Other Operating Expenses Regression Statistics

Arithmetic Mean109,614,110
Geometric Mean24,937,778
Coefficient Of Variation130.42
Mean Deviation125,053,262
Median19,735,000
Standard Deviation142,954,175
Sample Variance20435.9T
Range359M
R-Value0.88
Mean Square Error4854.2T
R-Squared0.78
Slope26,489,697
Total Sum of Squares306538.4T

Arcutis Other Operating Expenses History

2025363.1 M
2024345.8 M
2023300.7 M
2022305.3 M
2021206.5 M
2020136.6 M
201943.1 M

About Arcutis Biotherapeutics Financial Statements

Arcutis Biotherapeutics shareholders use historical fundamental indicators, such as Other Operating Expenses, to determine how well the company is positioned to perform in the future. Although Arcutis Biotherapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Arcutis Biotherapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Arcutis Biotherapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Operating Expenses345.8 M363.1 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Arcutis Stock Analysis

When running Arcutis Biotherapeutics' price analysis, check to measure Arcutis Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcutis Biotherapeutics is operating at the current time. Most of Arcutis Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Arcutis Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcutis Biotherapeutics' price. Additionally, you may evaluate how the addition of Arcutis Biotherapeutics to your portfolios can decrease your overall portfolio volatility.